№ lp_1_2_06113
File format: docx
Character count: 7721
File size: 127 KB
Clinical procedure detailing diagnostic criteria, treatment protocols, and monitoring steps for mild, moderate, and severe hyperkalaemia in adult patients, including relevant medications, interventions, and escalation to renal specialists.
Year:
2021
Organization:
Canberra Health Services
Document Type:
Procedure
Scope:
Adult patients within Canberra Health Service
Target Audience:
Medical Officers, Registered Nurses, Registered Midwives, Students under supervision, Pharmacists
Purpose:
Guide staff on management of hyperkalaemia in adults
Attachments:
Flow Chart: Hyperkalaemia in Adults – Decision Making Tool
Related Policies:
Informed Consent (Clinical), Medication Handling Procedures, Infection Prevention and Control, Patient Identification – Pathology Specimen Labelling, Access for Renal Replacement Therapy, Vital Signs and Early Warning Scores
Legislation:
Health Records (Privacy and Access) Act 1997, Human Rights Act 2004, Work Health and Safety Act 2011, Medicines, Poisons and Therapeutic Goods Act 2008, Therapeutic Goods Act 1989, Australian Charter of Healthcare Rights
References:
Australian Injectable Drugs Handbook, 8th edition, 2021
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / city:
Australia
Topic:
Chronic hyperkalaemia, kidney disease, sodium zirconium cyclosilicate
Document Type:
Submission to PBAC
Agency / organization:
AstraZeneca Pty Ltd
Author:
Not specified
Target audience:
Medical practitioners, healthcare professionals
Period of validity:
Ongoing, based on PBAC recommendation and PBS listing
Approval date:
1 September 2023
Date of amendments:
Not specified
Population:
Paediatric patients in cardiac arrest suspected to be caused by hyperkalaemia
Intervention:
Insulin with glucose or salbutamol
Comparison:
No insulin with glucose and no salbutamol
Main outcomes:
Survival to discharge; Survival to discharge with favourable neurological outcome (PCPC 1–3 or no change from baseline); Survival to discharge with PCPC 1–2 or no change from baseline
Setting:
Any setting
Perspective:
Not specified
Conflict of interests:
None
Problem priority:
Varies
Desirable effects:
Small
Undesirable effects:
Trivial
Certainty of evidence:
No included studies
Values and preferences:
Probably no important uncertainty or variability
Balance of effects:
Probably favors the intervention
Resources required:
Varies
Certainty of evidence of required resources:
No included studies
Cost effectiveness:
No included studies
Equity impact:
Unknown
Acceptability:
Unknown
Feasibility:
Probably yes
Year:
2020
Region / city:
Australia
Theme:
Health, pharmaceutical, clinical treatment
Document type:
Submission for drug listing
Organization / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Vifor Pharma Pty Limited
Target audience:
Healthcare professionals, regulatory bodies
Period of validity:
Ongoing
Approval date:
12 December 2017
Amendment date:
November 2020
Organisation:
Canberra Health Services
Region:
Canberra, Australian Capital Territory, Australia
Healthcare setting:
Hospital in the Home
Clinical area:
Cardiology
Condition:
Congestive cardiac failure
Patient population:
Adults
Type of document:
Clinical procedure
Route of administration:
Intravenous
Treatment:
Furosemide
Admission criteria:
Defined clinical and general eligibility requirements
Source type:
Institutional clinical guideline
Document type:
Memorandum
Request type:
Non-substantive change request
Subject:
Acute Respiratory Illness reporting for cruise ships
Program:
Phased Approach to the Resumption of Cruise Ship Passenger Operations
OMB Control Number:
0920-1335
OMB expiration date:
January 31, 2026
Issuing organization:
Centers for Disease Control and Prevention
Division:
National Center for Emerging and Zoonotic Infectious Diseases
Program contact:
Rudith Vice
Contact address:
1600 Clifton Road, NE, Atlanta, Georgia 30333
Contact phone:
404-718-7292
Contact email:
[email protected]
Date of document:
October 23, 2023
Effective date of proposed changes:
Upon receipt of OMB approval
Geographic scope:
United States
Regulatory reference:
42 CFR part 71
Target respondents:
Cruise ship physicians
Reporting system:
REDCap
Related attachment:
Attachment H_10202023
Year:
2027
Region / City:
United States
Topic:
Healthcare Technology, Medical Devices
Document Type:
Tracking Form
Agency / Organization:
Centers for Medicare & Medicaid Services
Author:
Unknown
Target Audience:
Healthcare Providers, Medical Device Manufacturers
Effective Period:
Fiscal Year 2027
Approval Date:
Unknown
Date of Changes:
Unknown
Acute Inpatient Psychiatric Admission Form for Patients Aged 10–17 with Neurodevelopmental Disorders
Patient Name:
____________________________________________
Date of Birth:
____________________
Home Address:
_________________________________________________________________________
Parent/Guardian Name/Phone/Email:
______________________________________________________
Expected Admission Type:
Voluntary / Involuntary
Referral for:
Acute Inpatient Psychiatric Treatment, approximately 30 days
Target Population:
Patients aged 10–17 with autism spectrum disorder, intellectual disability, or related neurodevelopmental disability
Current Psychiatric Provider:
UNC Psychiatry Outpatient (if applicable)
Diagnoses:
_____________________________________________________________________________
Current Medications:
____________________________________________________________________
Medical Problems:
______________________________________________________________________
Isolation Precautions:
No / Yes
Past Medical Hospitalizations or Surgeries:
__________________________________________________
Previous Psychiatric Treatment:
___________________________________________________________
Substance Use:
_________________________________________________________________________
Post-Treatment Residence Confirmed:
No / Yes
Department of Social Services / Child Protective Services Involvement:
_________________________
Consent for Medical Treatment:
___________________________________________________________
Last COVID Test:
___________________
Laboratory Results:
Within normal limits / Not done / Any abnormalities: ______________________
Pregnancy Status:
No / Yes
Seizure History:
No / Yes, well-controlled / Yes, uncontrolled
Last Vital Signs:
T______ P______ BP______ RR______ O2 Sat _____ Weight______ Height_______ BMI_________
Pending/Past Legal Problems:
_____________________________________________________________
ADL Support:
Independent / Needs Assistance with Eating, Hygiene, Walking (specify assist device)
Communication Method:
Verbally (sentences/words/phrases), Sign language, Pictures, Device, Gestures
Sensory Needs:
Hearing impaired / Visually impaired / Over/undersensitive to ____________________
Year:
2025
Region / city:
Cedar Crest College
Topic:
Clinical Nursing Education
Document Type:
Course Syllabus
Institution:
Cedar Crest College
Author:
Melissa Tracy, MSN, CRNP, ACNP-BC
Target Audience:
Graduate Nursing Students
Period of Validity:
Spring 2025
Approval Date:
N/A
Date of Last Revision:
N/A
Year:
2017
Region / city:
n/a
Topic:
Acute Normovolemic Hemodilution, Blood Conservation
Document Type:
Policy
Author:
AmSECT
Target Audience:
Surgeons, Anesthesiologists
Period of Validity:
n/a
Approval Date:
n/a
Revision Date:
n/a
Year:
2024
Region:
Massachusetts, USA
Document Type:
Transmittal Letter / Provider Manual Update
Issuing Organization:
Commonwealth of Massachusetts, Executive Office of Health and Human Services, Office of Medicaid
Author:
Monica Sawhney, Chief of Provider, Family, and Safety Net Programs
Target Audience:
Acute Outpatient Hospitals Participating in MassHealth
Effective Date:
July 1, 2024
Content Scope:
Revisions to drug codes, HCPCS codes, CPT codes, billing instructions, and procedural guidelines
Referenced Resources:
MassHealth Drug List, Centers for Medicare & Medicaid Services HCPCS website
Distribution:
MassHealth website and email alerts
Document type:
Policy
Sector:
Long-term care
Subject area:
Clinical assessment and monitoring
Applies to:
Residents of long-term care facilities
Responsible roles:
Attending Physician; Licensed Nurses; Nursing staff; Facility Assessment team
Clinical focus:
Acute change of condition
Key processes:
Assessment; Communication; Documentation; Monitoring; Transfer decisions
Referenced standards:
CMS State Operations Manual Appendix PP
Referenced programs:
INTERACT
Referenced regulation:
Medicare and Medicaid Programs Minimum Staffing Standards for Long-Term Care Facilities (CMS 3442-F)
Referenced literature:
Lippincott Manual of Nursing Practice
Publication references period:
2018–2024
Year:
2023
Region / City:
Australia
Theme:
Infectious Diseases Management, Healthcare
Document Type:
Guidelines
Organization:
Australian Government, Department of Health
Author:
Not specified
Target Audience:
Operators of residential care facilities
Action Period:
Ongoing
Approval Date:
16 May 2023
Amendment Date:
None
Context:
This document provides a comprehensive checklist for the management of acute respiratory infections, including COVID-19, influenza, and RSV, in residential care facilities.
Year:
2023
Region / City:
United Kingdom
Subject:
General practice specialty training, medical education
Document type:
Contract, Educational Guidelines
Organization / Institution:
HEE KSS, Acute Trust
Author:
Dr. Liz Norris, Professor Chris Warwick, Professor Graeme Dewhurst
Target audience:
GP specialty trainees, GP Educational Supervisors, Clinical Supervisors, Training Programme Directors
Effective period:
From placement start date to placement end date
Approval date:
Not specified
Amendment date:
Not specified
Year:
2017
Date:
December 8, 2017
Version:
1.0
Geographic scope:
Massachusetts
Issuing body:
Massachusetts Department of Public Health
Division:
Division of Epidemiology and Immunization
Document type:
Public health guidance and toolkit
Topic:
Carbapenem-resistant Enterobacteriaceae (CRE)
Settings covered:
Acute care, long-term care, outpatient and community-based healthcare settings
Target audience:
Healthcare workers, including physicians, epidemiologists, infection preventionists, nurses, pharmacists, and microbiologists
Related regulations:
105 CMR 300.000 Reportable Diseases, Surveillance, and Isolation and Quarantine Requirements
Funding source:
Centers for Disease Control and Prevention Epidemiology and Laboratory Capacity Grant
Year:
2023
Region / City:
Canberra, Australian Capital Territory (ACT)
Theme:
Acute Coronary Syndrome, STEMI, Medical Procedure
Document Type:
Standard Operating Procedure
Organization / Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Health care professionals working in acute coronary syndrome management
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Last Update:
Not specified
Note:
Year
Topic:
Infection control, Acute Respiratory Infection
Document type:
Procedure
Organ / institution:
Canberra Health Services
Target audience:
Healthcare staff, students, trainees, and contracted agents working in CHS Network
Year:
2026
Region / City:
United States
Topic:
Health Reporting
Document Type:
Reporting Form
Institution:
CDC (Centers for Disease Control and Prevention)
Author:
Centers for Disease Control and Prevention
Target Audience:
Cruise ship operators, public health authorities
Period of Validity:
Until 01/30/2026
Date of Approval:
01/30/2026
Date of Changes:
N/A
Note:
Year
Region / City:
Canberra
Topic:
Paediatric Care, Health Services
Document Type:
Guideline
Institution:
Canberra Health Services
Target Audience:
Medical, nursing, and allied health staff
Year:
2025
Document code:
CHS25/008
Country:
Australia
Region:
Australian Capital Territory
Subject:
Advance Care Planning
Document type:
Guideline
Issuing organisation:
Canberra Health Services
Target audience:
CHS Network staff
Population:
Adults aged 18 years and over
Care setting:
Inpatient, outpatient, and community health services
Legal framework:
Powers of Attorney Act 2006 and relevant state and territory legislation
Related systems:
Digital Health Record
Focus areas:
End-of-life care, substitute decision-making, culturally diverse populations, disability, elder abuse
Scope:
All Canberra Health Services Network facilities and services
Note:
Year
Topic:
Eating Disorders, Medical Management
Document Type:
Guideline
Organization / Institution:
Canberra Health Services
Target Audience:
Medical, nursing and allied health staff
Description:
Medical guideline for the management of adult patients with eating disorders in hospital settings.